Smoking Cessation for Cervical Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Cervical CancerTobacco UseSmoking Cessation
Interventions
BEHAVIORAL

Self-Help Materials

Participants receive free self-help materials mailed at baseline, 6, and 12 months. and a referral to the Oklahoma Quitline.

DRUG

Nicotine Patch

Participants receive a 12-week supply of nicotine patch. Nicotine patch regime based on participant's self-reported smoking rate. Participants who smoke \>10 cigarettes/day receive 8 weeks of 21 mg, 2 week of 14 mg, and 2 week of 7 mg patches. Those who smoke \<10 cigarettes/day receive 8 weeks of 14 mg and 4 weeks of 7 mg patches.

BEHAVIORAL

REDCap

REDCap will be used to collect all questionnaires data over the phone. Questionnaires done at baseline to randomize, then at 3, 6, 12, and 18 months.

PROCEDURE

Saliva Test

Saliva test performed at 3, 6, 12, and 18 months.

BEHAVIORAL

Telephone Counseling Sessions

6 telephone counseling sessions performed over 12 months. Sessions performed at baseline, 3, 6, 12, and 18 months. Sessions digitally recorded.

DRUG

Nicotine lozenge

Participants receive a 12-week supply of nicotine lozenges. All participants receive 12 weeks of 2mg lozenges.

Trial Locations (3)

33612

H Lee Moffitt Cancer Center and Research Institute, Tampa

73104

Oklahoma University Health Sciences Center, Oklahoma City

Stephenson Cancer Center, Oklahoma City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT02157610 - Smoking Cessation for Cervical Cancer Survivors | Biotech Hunter | Biotech Hunter